POZN News Alert Pozen Inc (POZN) 7.86 12/25/2014 11:33:19

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Pozen Inc (POZN) 7.86 $POZN

Nasdaq stocks posting largest percentage decreases
AP - Thu Dec 18, 12:48PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at 1 p.m.:
EGLT: 5.97 (+0.21), LNCO: 10.87 (-0.44), ASPS: 33.81 (+4.37), DERM: 19.65 (+0.38), MCEP: 6.07 (-0.12), GTIM: 6.13 (-0.07), LINE: 10.93 (-0.32), ORPN: 6.25 (-0.35), NYNY: 7.89 (+0.32), POZN: 7.86 (+0.07), OTIC: 32.26 (+0.65)

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pozen, Inc. - POZN
PR Newswire - Wed Dec 17, 1:24PM CST
Pomerantz LLP is investigating claims on behalf of investors of Pozen, Inc. ("Pozen" or the "Company" (NasdaqGS: POZN) (CUSIP: 73941U102). Investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 237.
POZN: 7.86 (+0.07)

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Wed Dec 17, 11:46AM CST

PTRY: 36.78 (+0.28), VIP: 4.07 (-0.26), CCM: 5.87 (-0.11), HGSH: 4.60 (-0.06), CLF: 6.06 (-0.09), ASPX: 49.93 (-0.10), SN: 9.91 (-0.71), NVGN: 2.40 (-0.09), NYNY: 7.89 (+0.32), FVE: 4.03 (-0.03), DRIV: 24.49 (+0.09), SGNL: 2.22 (-0.01), RT: 6.30 (+0.10), SFY: 4.47 (-0.06), VOLC: 17.95 (+0.02), WRES: 1.66 (-0.13), SGNT: 25.58 (+0.31), BBLU: 1.15 (-0.03), POZN: 7.86 (+0.07), XNCR: 16.83 (+0.77)

Premarket Gainers / Losers as of 9:10 am
Seeking Alpha - at Seeking Alpha - Wed Dec 17, 8:13AM CST

CERS: 6.49 (+0.29), FRO: 2.43 (-0.01), KNDI: 12.90 (+0.99), GFI: 4.37 (+0.13), CLF: 6.06 (-0.09), NVGN: 2.40 (-0.09), ASPX: 49.93 (-0.10), DRIV: 24.49 (+0.09), SID: 2.24 (-0.08), HALO: 9.34 (+0.31), VOLC: 17.95 (+0.02), POZN: 7.86 (+0.07), ICLD: 3.00 (-0.02), TASR: 26.86 (+0.84), DGLY: 15.62 (+0.82), SBGL: 7.13 (+0.20)

Pozen receives second CRL for Yosprala, shares drop
Seeking Alpha - at Seeking Alpha - Wed Dec 17, 7:28AM CST

POZN: 7.86 (+0.07)

POZEN's YOSPRALA(TM) Receives Complete Response Letter from The FDA
Business Wire - Wed Dec 17, 5:30AM CST
POZEN Inc. (NASDAQ: POZN), a pharmaceutical company committed to transforming medicine that transforms lives, announced today that their investigational drug candidates YOSPRALA(TM) 81/40 and 325/40 (aspirin / omeprazole delayed release tablets) have received a second complete response letter (CRL) from the U.S. Food and Drug Administration (FDA). A CRL is issued by the FDA when the review of the file is completed and questions remain that preclude the approval of the new drug application (NDA) in its current form.
POZN: 7.86 (+0.07)

Nasdaq makes annual changes to Biotechnology Index
Seeking Alpha - at Seeking Alpha - Mon Dec 15, 11:36AM CST

TTPH: 38.86 (+0.53), ZSPH: 43.93 (+1.77), AMRN: 0.99 (unch), OPHT: 44.93 (+1.06), AERI: 29.49 (+1.23), ASPX: 49.93 (-0.10), CNCE: 11.76 (+0.11), ICEL: 5.74 (-0.18), GWPH: 68.08 (+1.82), AUXL: 34.40 (+0.18), RTRX: 12.92 (+0.19), RCPT: 122.05 (+4.05), AAVL: 47.30 (-1.20), AKBA: 11.23 (-0.31), EXPR: 14.96 (+0.32), RARE: 45.17 (-0.56), RLYP: 30.35 (-0.22), PETX: 17.05 (+0.42), ENTA: 49.04 (+0.06), RDUS: 37.17 (+0.11), CARA: 9.78 (+0.02), FLML: 17.01 (-0.98), ALIM: 5.43 (-0.06), ANIP: 55.24 (+1.79), ICPT: 151.49 (+5.85), RVNC: 16.65 (+0.42), POZN: 7.86 (+0.07), FPRX: 26.12 (+0.07), ZFGN: 30.99 (+0.67), CRIS: 1.29 (+0.04), QLTI: 3.72 (+0.08), PCYC: 121.84 (+1.15), PTX: 9.05 (+0.28), CLDN: 18.54 (+0.85), RIGL: 2.22 (+0.02), HPTX: 21.91 (-0.08), AMPH: 11.74 (-0.09), INO: 9.11 (-0.09), VSAR: 22.25 (-0.11), FMI: 23.99 (-0.10), TBPH: 14.84 (+0.20), XLRN: 38.80 (+0.80), MGNX: 33.00 (+0.34), INSM: 15.29 (+0.15), ONTX: 3.82 (+0.06), ALDR: 25.67 (+0.43), SAGE: 38.13 (-0.75), KITE: 51.96 (+0.45), CGEN: 8.58 (-0.17), FOLD: 7.94 (+0.06), KPTI: 37.78 (+1.28)

Annual Changes to the NASDAQ Biotechnology Index
GlobeNewswire - Mon Dec 15, 6:10AM CST
The NASDAQ OMX Group, Inc. (Nasdaq:NDAQ) today announced the results of the annual re-ranking of the NASDAQ Biotechnology Index (Nasdaq:NBI), which will become effective prior to market open on Monday, December 22, 2014.
TTPH: 38.86 (+0.53), ZSPH: 43.93 (+1.77), AMRN: 0.99 (unch), OPHT: 44.93 (+1.06), AERI: 29.49 (+1.23), ASPX: 49.93 (-0.10), CNCE: 11.76 (+0.11), ICEL: 5.74 (-0.18), GWPH: 68.08 (+1.82), AUXL: 34.40 (+0.18), RTRX: 12.92 (+0.19), RCPT: 122.05 (+4.05), AAVL: 47.30 (-1.20), AKBA: 11.23 (-0.31), EXPR: 14.96 (+0.32), RARE: 45.17 (-0.56), ZGNX: 1.20 (+0.04), RLYP: 30.35 (-0.22), PETX: 17.05 (+0.42), ENTA: 49.04 (+0.06), RDUS: 37.17 (+0.11), CARA: 9.78 (+0.02), FLML: 17.01 (-0.98), ALIM: 5.43 (-0.06), ANIP: 55.24 (+1.79), ICPT: 151.49 (+5.85), RVNC: 16.65 (+0.42), POZN: 7.86 (+0.07), NDAQ: 48.74 (-0.40), FPRX: 26.12 (+0.07), CRIS: 1.29 (+0.04), ZFGN: 30.99 (+0.67), QLTI: 3.72 (+0.08), PCYC: 121.84 (+1.15), PTX: 9.05 (+0.28), CLDN: 18.54 (+0.85), RIGL: 2.22 (+0.02), HPTX: 21.91 (-0.08), AMPH: 11.74 (-0.09), INO: 9.11 (-0.09), VSAR: 22.25 (-0.11), FMI: 23.99 (-0.10), TBPH: 14.84 (+0.20), XLRN: 38.80 (+0.80), MGNX: 33.00 (+0.34), INSM: 15.29 (+0.15), ONTX: 3.82 (+0.06), ALDR: 25.67 (+0.43), SAGE: 38.13 (-0.75), KITE: 51.96 (+0.45), CGEN: 8.58 (-0.17), FOLD: 7.94 (+0.06), KPTI: 37.78 (+1.28)

Pozen Inc. Is A Great Opportunity For Investors
Mix Star - at Seeking Alpha - Sat Dec 13, 1:36PM CST

POZN: 7.86 (+0.07)

5 Stocks Insiders Can't Stop Buying: Titan International and More
at The Street - Wed Dec 10, 6:00AM CST
It's important to always be monitoring insider activity but twice as important to make sure the trend of the stock matches up with the insider buying.
DO: 38.66 (-0.62), HCOM: 27.34 (+0.27), POZN: 7.86 (+0.07), GLUU: 4.07 (-0.04), TWI: 10.92 (-0.20)

How To YieldBoost Pozen To 37.5% Using Options
at The Street - Mon Dec 08, 10:32AM CST
Shareholders of Pozen Inc. looking to boost their income beyond the stock's 19.1% annualized dividend yield can sell the June 2015 covered call at the $12 strike and collect the premium based on the 90 cents bid, which annualizes to an additional...
POZN: 7.86 (+0.07)

InsiderInsights.com Daily Round Up 12/3/14: VRX, PSEC, MATR, OCIP
InsiderInsights - at Seeking Alpha - Wed Dec 03, 11:28PM CST

VRX: 140.33 (-0.22), HCOM: 27.34 (+0.27), MATR: 6.09 (+0.03), ARI: 16.86 (-0.04), RENT: 75.98 (-0.75), LLY: 70.16 (+0.42), SPB: 97.15 (-0.49), GOOG: 528.77 (-1.82), DXPE: 51.55 (-0.41), K: 67.02 (-0.22), DO: 38.66 (-0.62), OCIP: 16.16 (-0.38), NOW: 69.69 (+0.12), COF: 83.23 (-0.05), DYN: 29.42 (+0.12), TWTR: 37.61 (+0.04), POZN: 7.86 (+0.07), DATA: 88.76 (+0.04), EL: 77.39 (-0.37), PSEC: 8.59 (-0.02)

POZEN (POZN) Is Weak On High Volume Today
at The Street - Wed Dec 03, 9:06AM CST
Trade-Ideas LLC identified POZEN (POZN) as a weak on high relative volume candidate
POZN: 7.86 (+0.07)

Migraine - Pipeline Review, H2 2014
M2 - Wed Dec 03, 7:48AM CST
Research and Markets (http://www.researchandmarkets.com/research/xq8n9b/migraine) has announced the addition of the "Migraine - Pipeline Review, H2 2014" report to their offering. This report provides comprehensive information on the therapeutic development for Migraine, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Migraine and special features on late-stage and discontinued projects. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. Reasons to buy - Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop strategic initiatives by understanding the focus areas of leading companies - Identify and understand important and diverse types of therapeutics under development for Migraine - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Devise corrective measures for pipeline projects by understanding Migraine pipeline depth and focus of Indication therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline Companies Mentioned: - Ache Laboratorios Farmaceuticos - Alder Biopharmaceuticals - Allergan - Amgen - Astellas Pharma - Avanir Pharmaceuticals - BioDelivery Sciences - Biofrontera - Bristol-Myers Squibb - D-Pharm - Eli Lilly and Company - Heptares Therapeutics - Impax Laboratories - IntelGenx - Istituto Italiano di Tecnologia - Medestea Research & Production - Merck & Co - Nektar Therapeutics - Northern Light Pharmaceuticals - Paladin Labs - Pfizer - Pozen - Proreo Pharma - Questcor Pharmaceuticals - Revance Therapeutics - TheraJect - Transcept Pharmaceuticals - Trigemina - Vertex Pharmaceuticals Incorporated - iCeutica For more information visit http://www.researchandmarkets.com/research/xq8n9b/migraine
VRTX: 115.15 (+1.40), AMGN: 160.67 (+3.15), LLY: 70.16 (+0.42), BMY: 59.15 (-0.01), NKTR: 15.02 (+0.23), AGN: 210.12 (+0.95), IPXL: 31.32 (+0.26), ALDR: 25.67 (+0.43), QCOR: 93.60 (+1.52), MRK: 57.46 (+0.25), TSPT: 1.70 (-0.04), RVNC: 16.65 (+0.42), POZN: 7.86 (+0.07)

Nasdaq stocks posting largest volume increases
AP - Tue Dec 02, 5:04PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
CY: 14.61 (+0.26), FBNK: 16.50 (unch), SHBI: 9.45 (+0.05), VGGL: 2.89 (+0.04), QDEL: 27.86 (-0.17), ISIG: 3.78 (+0.02), POZN: 7.86 (+0.07), PFBX: 12.97 (+0.14), IROQ: 16.83 (-0.12), ORPN: 6.25 (-0.35), OBAS: 7.04 (-0.46)

POZEN (POZN) Is Strong On High Volume Today
at The Street - Tue Dec 02, 9:05AM CST
Trade-Ideas LLC identified POZEN (POZN) as a strong on high relative volume candidate
POZN: 7.86 (+0.07)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

CVS Puts Youth Soccer Stories on Its Store Shelves

Updated Category News Views 76

Two kids with real community ties just got a megaphone most grown-ups never receive. CVS Pharmacy has named Caroline, 9, of Holmes Beach, Florida, and Zoe, 12, of Los Angeles, as the first grand-prize winners of its Home Team Heroes youth soccer contest. Each player’s selected nonprofit soccer organization will receive a $25,000 grant, while their stories will appear on...

Continue Reading
Automus and Google Cloud Put Agents to Work on Oracle

Updated Category News Views 96

Oracle back offices are where shiny AI promises go to earn their keep, or get buried under a mountain of integrations. Automus Consulting’s newly announced collaboration with Google Cloud, unveiled November 20 at Oracle AI World, is aimed squarely at that messy middle. The firm wants to combine its Oracle implementation experience with Google Cloud infrastructure and...

Continue Reading
Workers Are Burning Savings as Pay Falls Behind Costs

Updated Category News Views 69

Payroll optimism has been ground into dust by the ordinary bills nobody can dodge. Monster's 2026 Cost of Living Report says 93% of employed U.S. workers feel their wages are failing to keep up with costs, barely different from 95% in both 2024 and 2025. That is not a blip, and it is not workers merely grousing about prices. Three years of nearly identical frustration...

Continue Reading
PayPal's New Leadership Map Puts Execution on Trial

Updated Category News Views 106

Four senior appointments and a risk-chief exit can turn a tidy strategy slide into a very real operating test. PayPal has spent months defining three-year plans, simplifying its operating model and assigning clearer accountability; on November 20, it put names beside the jobs. For NASDAQ:PYPL investors, that is more consequential than another broad promise about...

Continue Reading
SoCalGas Data Program Puts Metering Case Into Focus

Updated Category News Views 61

Buried beneath the usual utility-company polish is a pretty sensible idea: find waste before a customer gets walloped by a bill. SoCalGas says its Advanced Meter Analytics program has helped customers avoid an estimated $11 million in unnecessary natural-gas costs since 2019. That is not a number likely to move Sempra’s earnings by itself, and nobody should pretend...

Continue Reading
YPTC’s Florida Office Bets on Nonprofit Finance Needs

Updated Category News Views 50

A Local Flag Planted After Years of Work Florida nonprofits do not need another consultant waving a glossy slide deck around; they need clean books, grant compliance, and somebody who can tell them where the cash is going before the lights start blinking red. That is the practical opening YPTC is chasing with a Jacksonville-based Florida office, its sixteenth office...

Continue Reading
GreenTree Faces Softer Rooms, Debt and NYSE Deadline

Updated Category News Views 34

A hotel operator can post positive earnings and still leave shareholders with a nasty headache, and GreenTree's third quarter is that kind of report. NYSE:GHG produced RMB243.0 million in revenue, down 22.2% from a year earlier, while net income slipped to RMB49.3 million from RMB59.0 million. This was not a one-line stumble. Room pricing, occupancy, franchise economics...

Continue Reading
Swim Readiness Depends on Skills, Not Birthdays Alone

Updated Category News Views 55

A child popping up calmly after a brief dunk tells you more than a birthday ever will. That is the sensible center of Woody Alpern's guidance for families weighing whether a child belongs in the next swim level. The Atlanta swim school expert's point is refreshingly free of the usual parental race: advancement is earned through repeatable skills, comfort, and judgment in...

Continue Reading
Travel Awards Spotlight Luxury Hospitality's Reach

Updated Category News Views 90

Hong Kong’s awards roll call reads less like a scorecard than a map of where premium travel wants its money and attention to go next. The 2026 World’s Travel & Hotel Awards, released November 20, cast a very wide net: heritage palaces, city hotels, beach retreats, airlines, cruise operators, tourism boards, restaurants, serviced apartments and a fair number of...

Continue Reading
TEN Holdings Raises $1.0 Million as Dilution Looms

Updated Category News Views 66

A Small Raise With a Loud Message Nothing says “we need room to breathe” quite like selling 1,492,500 new shares for $0.67 apiece. TEN Holdings closed a roughly $1.0 million gross equity offering on November 20, 2026, and investors in NASDAQ:XHLD ought to look at this for what it is: a modest cash infusion that comes with immediate dilution. The company gets capital;...

Continue Reading

Top 5 Most Recently Viewed Articles

GoldHaven Resources Expands Exploration Amid Robust Gold Prices

Updated Category News Views 299

Gold's Resilience Fuels Growth Initiatives Gold prices have steadily stabilized above $4,200 per ounce, prompting renewed interest among investors seeking safe-haven assets. This robust price environment encourages extensive drilling programs aimed at expanding resource bases. GoldHaven Resources Corp. (CSE: GOH) is at the forefront of this momentum, actively advancing...

Continue Reading
HSBC Highlights Reliance Industries' Growth Potential and Strategy

Updated Category News Views 287

HSBC Upgrades Reliance Industries Stock Target Recently, HSBC raised its price target for Reliance Industries (RIL:IN) from INR 2,780.00 to INR 3,010.00 while maintaining a Hold rating. This revision reflects a promising outlook on the company's comprehensive business structure and financial standing. Core Sectors Driving Performance HSBC's analysts highlighted Reliance's...

Continue Reading
Vallourec's Strategic Move: Partial Redemption of Notes

Updated Category News Views 142

Vallourec's Strategic Financial Maneuver Vallourec, an industry leader in premium tubular solutions, has made a significant announcement regarding its senior notes due 2032. This decision is part of its ongoing strategy to enhance its financial stability and market position. Details of the Partial Redemption The company plans to redeem $82 million of its senior notes,...

Continue Reading
Health Assurance Foundation Teams Up to Enhance Healthcare Access

Updated Category News Views 80

The Health Assurance Foundation officially launched as a nonprofit back in 2024, focusing on strengthening the healthcare system by investing in local communities. Its mission? Making healthcare more equitable and accessible for everyone. Sounds good on paper, right? But when you peel back the layers, things get murky. Community Health Worker Initiative: Is It Enough? The...

Continue Reading
Market Pay Unveils Seamless POS Solution for Merchants Across Europe

Updated Category News Views 208

Market Pay Launches a Game-Changing Payment Solution The French fintech company Market Pay, a prominent player in the European payment processing field, is excited to unveil its new point-of-sale software payment solution. This innovative app integrates both terminal and smartphone payment options into a single, user-friendly platform. This development not only simplifies...

Continue Reading